Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thallium is a heavy metal element (atomic number 81) that is not a biological target but rather a potent systemic toxicant and a diagnostic tool in nuclear medicine (StatPearls: NBK507803). It exerts its biological effects primarily by mimicking potassium ions (K+), as it possesses a similar ionic radius, allowing it to be transported into cells via the Na+/K+-ATPase pump and various potassium channels (Wikipedia: Thallium). This mimicry leads to the disruption of essential potassium-dependent processes, including oxidative phosphorylation and protein synthesis, resulting in multi-organ toxicity characterized by alopecia and peripheral neuropathy (PubChem: CID 5359484). In clinical settings, the radioisotope Thallium-201 is utilized as a tracer for myocardial perfusion imaging to assess coronary artery disease and myocardial viability (NIH: Thallium-201). Because it is an element and a toxicant rather than a therapeutic protein or receptor, it is classified as an incorrect target for drug development, though its removal is the goal of specific antidotes like Prussian blue (NIH: Prussian Blue).
Thallium acts as a potassium analogue, entering cells via the Na+/K+-ATPase pump and voltage-gated potassium channels due to its similar ionic radius to potassium (StatPearls: NBK507803). Once inside, it interferes with energy production by inhibiting enzymes like pyruvate kinase and succinate dehydrogenase (PubChem: CID 5359484).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thallium (Tl).